Emergent BioSolutions (EBS) Accumulated Expenses (2009 - 2026)
Emergent BioSolutions (EBS) recorded Accumulated Expenses of $7.5 million in Q3 2026, down 46.0% from $13.9 million a year earlier and down 56.1% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions reported Accumulated Expenses of $12.2 million, down 31.1% from FY2024.
- Annual Accumulated Expenses has declined for four straight years, with a five-year compound annual growth rate of -23.6% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $17.7 million in FY2024 (-4.8%), $18.6 million in FY2023 (-46.7%), $34.9 million in FY2022 (-32.5%) and $51.7 million in FY2021 (+10.2%).
- The Q3 2026 figure is the lowest quarterly Accumulated Expenses since Q3 2018.
- On a year-over-year basis, Accumulated Expenses rose in 1 of the last eight quarters, with an average decline of 15.9%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 25.7% in Q2 2026, against a decline of 52.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $17.1 million (Q2 2026), $9.4 million (Q1 2026) and $12.2 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 309.85 Mn | -371.25 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.50 Mn |
| Jun 30, 2026 | 17.10 Mn |
| Mar 31, 2026 | 9.40 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Sep 30, 2025 | 13.90 Mn |
| Jun 30, 2025 | 13.60 Mn |
| Mar 31, 2025 | 13.20 Mn |
| Dec 31, 2024 | 17.70 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | 17.20 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Dec 31, 2023 | 18.60 Mn |
| Sep 30, 2023 | 17.00 Mn |
| Jun 30, 2023 | 31.20 Mn |
| Mar 31, 2023 | 21.30 Mn |
| Dec 31, 2022 | 34.90 Mn |
| Sep 30, 2022 | 35.70 Mn |
| Jun 30, 2022 | 40.30 Mn |
| Mar 31, 2022 | 29.30 Mn |
| Dec 31, 2021 | 51.70 Mn |
API Access
Emergent BioSolutions Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();